Vaxart Inc (VXRT) stock news · rev $237.3M
Vaxart Inc (VXRT) is a biotechnology company listed on US.
This VXRT news page leads with what Vaxart Inc filed — not a scraped headline mill.
No cached 8-K sentence for VXRT yet. We will not pad this page with generic market recap.
Latest reported VXRT revenue for 2025-12-31 was $237.3M. Net income was $16.3M. Revenue was up 726.7% from 2024-12-31 to 2025-12-31. VXRT currently screens at market cap $73.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VXRT stock page; for the tape open the quote page.
VXRT stock news FAQ
What are VXRT's latest revenue and net income?
Latest cached Vaxart Inc (VXRT) revenue for Dec 31, 2025 was $237.3M. Net income was $16.3M. Statements: https://lician.com/financials/vxrt
How did VXRT revenue change from the prior cached period?
Cached Vaxart Inc (VXRT) revenue was up 726.7% from $28.7M (Dec 31, 2024) to $237.3M (Dec 31, 2025). Statements: https://lician.com/financials/vxrt
What is VXRT's market cap?
Vaxart Inc (VXRT) market cap is $73.0M on the latest cached fundamentals snapshot.
What kind of company is VXRT?
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Where is VXRT stock news listed?
Cached stock news for Vaxart Inc (VXRT) is listed at https://lician.com/news/vxrt. Filings: https://lician.com/sec/vxrt
Not investment advice.